Scopia Capital Management 13F holdings, Q2 2017
Holdings as of June 30, 2017 · filings on SEC EDGAR · latest filing →
Scopia Capital Management disclosed 34 US equity positions worth $4.8bn in its Q2 2017 13F filing. The largest position was FOREST CITY RLTY TR INC at 11.9% of the reported book, followed by S9Q and NFLX. Against the Q1 2017 filing, it opened 7 new positions, added to 9 and reduced 8 among the top 34 holdings.
What did Scopia Capital Management own in Q2 2017? Top 34 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2017 |
|---|---|---|---|---|---|---|---|
| 1 | FOREST CITY RLTY TR INC | 11.9% | $570.1m | 23,585,735 | -0% | held | |
| 2 | S9Q SPIRIT AEROSYSTEMS HLDGS INC | 9.0% | $432.3m | 7,460,682 | 13% | added | |
| 3 | NFLX NETFLIX INC | Communication Services | 8.0% | $380.2m | 2,544,460 | -0% | held |
| 4 | ITRI ITRON INC | Technology | 6.5% | $308.8m | 4,558,387 | 0% | held |
| 5 | BIDU BAIDU INC | Communication Services | 6.1% | $291.9m | 1,631,838 | -8% | reduced |
| 6 | JCI JOHNSON CTLS INTL PLC | Industrials | 5.3% | $255.3m | 5,887,736 | -22% | reduced |
| 7 | GWPH GW PHARMACEUTICALS PLC | 5.2% | $250.1m | 2,494,738 | 25% | added | |
| 8 | JD JD COM INC | Consumer Cyclical | 5.1% | $244.2m | 6,225,674 | -42% | reduced |
| 9 | HORIZON PHARMA PLC | 3.8% | $181.7m | 15,308,143 | 58% | added | |
| 10 | SPIRIT RLTY CAP INC NEW | 3.3% | $157.8m | 21,301,460 | – | new | |
| 11 | TEAM HEALTH HOLDINGS INC | 3.0% | $145.2m | 3,338,649 | 0% | held | |
| 12 | ACORDA THERAPEUTICS INC | 3.0% | $142.3m | 7,223,906 | 30% | added | |
| 13 | CNMD CONMED CORP | Healthcare | 3.0% | $141.3m | 2,774,045 | 0% | held |
| 14 | NEURODERM LTD | 2.7% | $131.1m | 4,383,358 | 0% | held | |
| 15 | FNF FIDELITY NATIONAL FINANCIAL | Financial Services | 2.7% | $129.9m | 2,897,201 | -10% | reduced |
| 16 | OPTU ALTICE USA INC | Communication Services | 2.5% | $117.2m | 3,629,740 | – | new |
| 17 | RETROPHIN INC | 2.4% | $115.8m | 5,973,111 | 2% | added | |
| 18 | CNDT CONDUENT INC | Technology | 2.3% | $111.2m | 6,979,221 | 136% | added |
| 19 | VST VISTRA ENERGY CORP | Utilities | 2.2% | $106.2m | 6,324,010 | – | new |
| 20 | AR ANTERO RES CORP | Energy | 2.1% | $100.4m | 4,643,955 | 37% | added |
| 21 | CONSOL ENERGY INC | 2.0% | $95.0m | 6,359,895 | 16% | added | |
| 22 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 1.9% | $91.5m | 705,003 | -70% | reduced |
| 23 | LGND LIGAND PHARMACEUTICALS INC | Healthcare | 1.9% | $88.4m | 728,563 | -37% | reduced |
| 24 | TRGP TARGA RES CORP | Energy | 1.8% | $87.3m | 1,930,592 | 31% | added |
| 25 | ADVANCED ACCELERATOR APPLIC | 0.9% | $41.8m | 1,070,163 | -13% | reduced | |
| 26 | ANTERO MIDSTREAM GP LP | 0.4% | $20.6m | 935,053 | – | new | |
| 27 | ENTERCOM COMMUNICATIONS CORP | 0.3% | $12.9m | 1,247,952 | – | new | |
| 28 | ACH OWENS & MINOR INC NEW | Healthcare | 0.3% | $12.5m | 387,901 | – | new |
| 29 | INTELSAT S A | 0.1% | $4.6m | 1,487,257 | -26% | reduced | |
| 30 | FOSL FOSSIL GROUP INC | Consumer Cyclical | 0.1% | $4.1m | 395,925 | 0% | held |
| 31 | MERSANA THERAPEUTICS INC | 0.1% | $2.8m | 203,626 | – | new | |
| 32 | MNKD MANNKIND CORP | Healthcare | 0.0% | $1.4m | 982,930 | 0% | held |
| 33 | PROSPECT CAPITAL CORPORATION | 0.0% | $846.0k | 104,194 | 0% | held | |
| 34 | AMSC AMERICAN SUPERCONDUCTOR CORP | Industrials | 0.0% | $91.0k | 19,610 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.